Cancer

INDICATION: Acute myelogenous leukemia (AML)

Cell culture studies identified a pteridinylbenzamide-based dual PLK1/BRD4 inhibitor that could help treat AML. Chemical synthesis and screening of

Read the full 234 word article

User Sign In